CN113402471B - 来源于植物内生真菌的铁载体类化合物及制备方法与应用 - Google Patents
来源于植物内生真菌的铁载体类化合物及制备方法与应用 Download PDFInfo
- Publication number
- CN113402471B CN113402471B CN202110563340.5A CN202110563340A CN113402471B CN 113402471 B CN113402471 B CN 113402471B CN 202110563340 A CN202110563340 A CN 202110563340A CN 113402471 B CN113402471 B CN 113402471B
- Authority
- CN
- China
- Prior art keywords
- compound
- siderophore
- gliocladin
- culture medium
- endophytic fungi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 160
- 239000000589 Siderophore Substances 0.000 title claims abstract description 46
- 241000233866 Fungi Species 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims description 20
- 241001149472 Clonostachys rosea Species 0.000 claims abstract description 24
- 230000000694 effects Effects 0.000 claims abstract description 22
- 238000012258 culturing Methods 0.000 claims abstract description 20
- 239000003814 drug Substances 0.000 claims abstract description 14
- 229940079593 drug Drugs 0.000 claims abstract description 12
- 229930188191 gliocladin Natural products 0.000 claims description 93
- 239000001963 growth medium Substances 0.000 claims description 37
- 241000196324 Embryophyta Species 0.000 claims description 32
- 238000000855 fermentation Methods 0.000 claims description 29
- 230000004151 fermentation Effects 0.000 claims description 29
- 239000007787 solid Substances 0.000 claims description 28
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 239000000047 product Substances 0.000 claims description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 16
- 244000061456 Solanum tuberosum Species 0.000 claims description 16
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 16
- 239000008103 glucose Substances 0.000 claims description 16
- 239000000243 solution Substances 0.000 claims description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 14
- 238000011218 seed culture Methods 0.000 claims description 12
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 210000002865 immune cell Anatomy 0.000 claims description 9
- 239000008223 sterile water Substances 0.000 claims description 9
- 241000894006 Bacteria Species 0.000 claims description 8
- 239000002609 medium Substances 0.000 claims description 8
- 238000004321 preservation Methods 0.000 claims description 8
- 229920001817 Agar Polymers 0.000 claims description 6
- 239000008272 agar Substances 0.000 claims description 6
- 238000001704 evaporation Methods 0.000 claims description 6
- 238000002955 isolation Methods 0.000 claims description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 239000002352 surface water Substances 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 240000007594 Oryza sativa Species 0.000 claims description 5
- 235000007164 Oryza sativa Nutrition 0.000 claims description 5
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims description 5
- 229940126214 compound 3 Drugs 0.000 claims description 5
- 230000006698 induction Effects 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 238000004007 reversed phase HPLC Methods 0.000 claims description 5
- 235000009566 rice Nutrition 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- 229940124350 antibacterial drug Drugs 0.000 claims description 4
- 229940125904 compound 1 Drugs 0.000 claims description 4
- 229940125782 compound 2 Drugs 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 239000011521 glass Substances 0.000 claims description 4
- 210000002540 macrophage Anatomy 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 244000025254 Cannabis sativa Species 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 229930182555 Penicillin Natural products 0.000 claims description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 3
- 239000005708 Sodium hypochlorite Substances 0.000 claims description 3
- 239000002250 absorbent Substances 0.000 claims description 3
- 230000002745 absorbent Effects 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 244000052616 bacterial pathogen Species 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 238000011109 contamination Methods 0.000 claims description 3
- 239000000287 crude extract Substances 0.000 claims description 3
- 238000005520 cutting process Methods 0.000 claims description 3
- 230000002708 enhancing effect Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000003306 harvesting Methods 0.000 claims description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 3
- 230000001939 inductive effect Effects 0.000 claims description 3
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 229940049954 penicillin Drugs 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 238000010008 shearing Methods 0.000 claims description 3
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims description 3
- 229960005322 streptomycin Drugs 0.000 claims description 3
- 241000675278 Candida albicans SC5314 Species 0.000 claims description 2
- 238000012136 culture method Methods 0.000 claims description 2
- 238000011049 filling Methods 0.000 claims description 2
- 230000001717 pathogenic effect Effects 0.000 claims description 2
- 238000007747 plating Methods 0.000 claims 1
- 241000244206 Nematoda Species 0.000 abstract description 14
- 230000004083 survival effect Effects 0.000 abstract description 10
- 208000032536 Pseudomonas Infections Diseases 0.000 abstract description 5
- 239000000843 powder Substances 0.000 description 66
- 238000001228 spectrum Methods 0.000 description 32
- 238000005100 correlation spectroscopy Methods 0.000 description 9
- 238000002114 high-resolution electrospray ionisation mass spectrometry Methods 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 229940125898 compound 5 Drugs 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000001052 heteronuclear multiple bond coherence spectrum Methods 0.000 description 6
- 238000000990 heteronuclear single quantum coherence spectrum Methods 0.000 description 6
- 239000002243 precursor Substances 0.000 description 6
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 5
- 230000001851 biosynthetic effect Effects 0.000 description 5
- 229940095731 candida albicans Drugs 0.000 description 5
- 238000002211 ultraviolet spectrum Methods 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 241000222122 Candida albicans Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 238000003919 heteronuclear multiple bond coherence Methods 0.000 description 3
- 238000005570 heteronuclear single quantum coherence Methods 0.000 description 3
- 238000010829 isocratic elution Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 241000896533 Gliocladium Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000003042 antagnostic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001032 anti-candidal effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 244000000004 fungal plant pathogen Species 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000009629 microbiological culture Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 230000003071 parasitic effect Effects 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- QSPMXWIFLDIBGD-UHFFFAOYSA-N (2RS,3SR,4E,8E)-1-O-(beta-D-glucopyranosyl)-3-hydroxy-2-{[(2SR,3E)-2-hydroxy-3-octadecenoyl]amino}-9-methyloctadeca-4,8-diene Natural products CCCCCCCCCCCCCCC=CC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O QSPMXWIFLDIBGD-UHFFFAOYSA-N 0.000 description 1
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- PXDBPPDTZJGMIG-UHFFFAOYSA-N Cerebroside C Natural products CCCCCCCCCCCCC=CCCC(O)C(=O)NC(COC1OC(CO)C(O)C(O)C1O)C(O)C=CCCC=C(/C)CCCCCCCCC PXDBPPDTZJGMIG-UHFFFAOYSA-N 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 108010069514 Cyclic Peptides Proteins 0.000 description 1
- 102000001189 Cyclic Peptides Human genes 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000233614 Phytophthora Species 0.000 description 1
- 241000223960 Plasmodium falciparum Species 0.000 description 1
- 241000222383 Polyporales Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000233639 Pythium Species 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 244000007853 Sarothamnus scoparius Species 0.000 description 1
- 241001149558 Trichoderma virens Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000078 anti-malarial effect Effects 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000443 biocontrol Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
- 229960003677 chloroquine Drugs 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 229930188952 gliocladine Natural products 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000001069 nematicidal effect Effects 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- 231100000208 phytotoxic Toxicity 0.000 description 1
- 230000000885 phytotoxic effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
- C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Botany (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110563340.5A CN113402471B (zh) | 2021-05-24 | 2021-05-24 | 来源于植物内生真菌的铁载体类化合物及制备方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110563340.5A CN113402471B (zh) | 2021-05-24 | 2021-05-24 | 来源于植物内生真菌的铁载体类化合物及制备方法与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113402471A CN113402471A (zh) | 2021-09-17 |
CN113402471B true CN113402471B (zh) | 2022-09-13 |
Family
ID=77679312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110563340.5A Active CN113402471B (zh) | 2021-05-24 | 2021-05-24 | 来源于植物内生真菌的铁载体类化合物及制备方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113402471B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103261398A (zh) * | 2010-02-25 | 2013-08-21 | 马罗内生物创新公司 | 伯克霍尔德氏菌属的分离细菌菌株及其农药代谢物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040186087A1 (en) * | 2003-03-20 | 2004-09-23 | Ceramoptec Industries, Inc. | Siderophore conjugates of photoactive dyes for photodynamic therapy |
CN107058160B (zh) * | 2016-12-29 | 2019-06-21 | 山东农业大学 | 一株花生根际解淀粉芽孢杆菌及其应用 |
-
2021
- 2021-05-24 CN CN202110563340.5A patent/CN113402471B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103261398A (zh) * | 2010-02-25 | 2013-08-21 | 马罗内生物创新公司 | 伯克霍尔德氏菌属的分离细菌菌株及其农药代谢物 |
Also Published As
Publication number | Publication date |
---|---|
CN113402471A (zh) | 2021-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11459593B2 (en) | Dendrobium officinale endophytic fungus strain and extracellular polysaccharide produced thereby, and extraction method and application of extracellular polysaccharide | |
CN103952362A (zh) | 一株对多种植物病原菌具抑菌活性的柑橘内生放线菌 | |
CN110452247A (zh) | 一种杂萜化合物及其制备方法和应用 | |
WO2022247190A1 (zh) | 一种高产喜树碱内生菌株及其应用 | |
CN118291575A (zh) | 一种稀有人参皂苷ck的制备方法及应用 | |
CN108102928B (zh) | 一株银杏内生真菌及其应用 | |
Zhang et al. | Enhancement of diosgenin production in Dioscorea zingiberensis cell culture by oligosaccharide elicitor from its endophytic fungus Fusarium oxysporum Dzf17 | |
CN113402471B (zh) | 来源于植物内生真菌的铁载体类化合物及制备方法与应用 | |
CN103408550A (zh) | 来源于产酶溶杆菌的2,5-二酮哌嗪类二肽及其制备和应用 | |
CN112961783A (zh) | 一株植物内生真菌及其在制备螺环内酯衍生物中的应用 | |
CN108191693B (zh) | 一种防治白色念珠菌化合物及其制备方法与应用 | |
CN111807946B (zh) | 一种Pratensinon A化合物及其制备和应用 | |
CN108102933A (zh) | 一株白黄黑链霉菌菌株及其应用 | |
CN110343618B (zh) | 一类helminthosporol型倍半萜类化合物及其制备方法与应用 | |
CN110272345B (zh) | 一类来源于植物病原真菌的5-15环二倍半萜化合物及其制备方法与应用 | |
CN104293710B (zh) | 链霉菌菌株及其防治辣椒立枯病联合应用 | |
CN109180593B (zh) | 酚嗪生物碱类次生代谢产物及其应用 | |
CN108165514B (zh) | 一株芽孢杆菌及其发酵产物和应用 | |
CN117305388B (zh) | 贝莱斯芽孢杆菌sl-k2在制备鸟嘌呤提取物中的应用、鸟嘌呤提取物的制备方法及应用 | |
CN112760235A (zh) | 一株老鼠簕内生真菌Diaporthe goulteri及其代谢产物的应用 | |
CN114350529B (zh) | 一株产查尔酮类成分的甘草内生真菌及其应用 | |
CN111533756A (zh) | 来源于植物病原真菌的螺缩酮类化合物及制备方法与应用 | |
CN103361276A (zh) | 刺糖多孢菌hberc-25376及其培养、活性物质的分离方法与应用 | |
CN101525578A (zh) | 盾叶薯蓣内生真菌螺二萘类化合物的制备及作为杀菌剂的应用 | |
CN108130305B (zh) | 一株枯草芽孢杆菌及其在防治西洋参根腐线虫病中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240521 Address after: 253000, located on the east side of East Second Road of the Expressway in Songguantun Street Office, Economic and Technological Development Zone, Dezhou City, Shandong Province, China. Located on the south side of Jiangkou Biotechnology Company (Workshop 3, Shandong Xiangyu Solar Energy Technology Co., Ltd.) Patentee after: Dezhou Paide Pet Food Co.,Ltd. Country or region after: China Address before: 200237 No. 130, Meilong Road, Shanghai, Xuhui District Patentee before: EAST CHINA University OF SCIENCE AND TECHNOLOGY Country or region before: China |